Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Aalter, 06/01/2021 Delivery of the first vaccines by the hospitals to the residential care centers . Yesterday the first 890 vaccines from Pfizer-BioNTech were delivered to four Flemish hospitals. From today residents and staff members in 42 residential care centers in Flanders will receive the first dose of the vaccine. First step of the vaccination campaign at the Woonhave in Aalter Pix : Pfizer-BioNTech Vaccine Delivery Credit : Frederic Sierakowski / Isopix

Pfizer / BioNTech first set of vaccinations against COVID-19 at the puncture site in Veghel. Sanna Elkadiri nursing home employee who receives the first vaccine a syringe with the vaccine vaccination obligation corona vaccine. Providers of acute care, such as ambulance staff and IC staff, are stimulated against the coronavirus in various hospitals. Veghel, Netherlands on January 6, 2021. Photo by Robin Utrecht/ABACAPRESS.COM

BELGRADE, SERBIA - JANUARY 6: (---EDITORIAL USE ONLY ??" MANDATORY CREDIT - "SERBIAN INTERIOR MINISTRY / HANDOUT" - NO MARKETING NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS----) A health personnel holds a dose of Sputnik V coronavirus vaccine as Serbian parliament speaker Ivica Dacic and Serbian Interior Minister Aleksandar Vulin receive Russia???s Sputnik V coronavirus vaccine in Belgrade, Serbia on January 6, 2021. Serbian Interior Ministry / handout / Anadolu Agency/ABACAPRESS.COM

BELGRADE, SERBIA - JANUARY 6: (---EDITORIAL USE ONLY ??" MANDATORY CREDIT - "SERBIAN INTERIOR MINISTRY / HANDOUT" - NO MARKETING NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS----) A dose of Sputnik V coronavirus vaccine is seen as Serbian parliament speaker Ivica Dacic and Serbian Interior Minister Aleksandar Vulin receive Russia???s Sputnik V coronavirus vaccine in Belgrade, Serbia on January 6, 2021. Serbian Interior Ministry / handout / Anadolu Agency/ABACAPRESS.COM

Pfizer / BioNTech first set of vaccinations against COVID-19 at the puncture site in Veghel. Sanna Elkadiri nursing home employee who receives the first vaccine a syringe with the vaccine vaccination obligation corona vaccine. Providers of acute care, such as ambulance staff and IC staff, are stimulated against the coronavirus in various hospitals. Veghel, Netherlands on January 6, 2021. Photo by Robin Utrecht/ABACAPRESS.COM

Pfizer / BioNTech first set of vaccinations against COVID-19 at the puncture site in Veghel. Sanna Elkadiri nursing home employee who receives the first vaccine a syringe with the vaccine vaccination obligation corona vaccine. Providers of acute care, such as ambulance staff and IC staff, are stimulated against the coronavirus in various hospitals. Veghel, Netherlands on January 6, 2021. Photo by Robin Utrecht/ABACAPRESS.COM

Pfizer / BioNTech first set of vaccinations against COVID-19 at the puncture site in Veghel. Sanna Elkadiri nursing home employee who receives the first vaccine a syringe with the vaccine vaccination obligation corona vaccine. Providers of acute care, such as ambulance staff and IC staff, are stimulated against the coronavirus in various hospitals. Veghel, Netherlands on January 6, 2021. Photo by Robin Utrecht/ABACAPRESS.COM

Pfizer / BioNTech first set of vaccinations against COVID-19 at the puncture site in Veghel. Sanna Elkadiri nursing home employee who receives the first vaccine a syringe with the vaccine vaccination obligation corona vaccine. Providers of acute care, such as ambulance staff and IC staff, are stimulated against the coronavirus in various hospitals. Veghel, Netherlands on January 6, 2021. Photo by Robin Utrecht/ABACAPRESS.COM

Pfizer / BioNTech first set of vaccinations against COVID-19 at the puncture site in Veghel. Sanna Elkadiri nursing home employee who receives the first vaccine a syringe with the vaccine vaccination obligation corona vaccine. Providers of acute care, such as ambulance staff and IC staff, are stimulated against the coronavirus in various hospitals. Veghel, Netherlands on January 6, 2021. Photo by Robin Utrecht/ABACAPRESS.COM

CureVac Symbolbild Covid-19 Impfstoffdose mit Spritze Corona-Impfstoff *** CureVac Icon Covid 19 Vaccine Can with Syringe Corona Vaccine

Die Impfkampagne gegen das Coronavirus in Deutschland lauft schleppend an. Unter Klinik- und Heimpersonal fiel die Impfbereitschaft gering aus. Nach dem Impfstoff von Biontech Pfizer hat die Europaische Arzneimittelbeh?rde hat nun auch dem Impfstoff des US-Herstellers Moderna eine Zulassung erteilt. Themenbild, Symbolbild K?ln, 06.01.2021 *** The vaccination campaign against the Coronavirus in Germany runs sluggishly Among hospital and home personnel the vaccination readiness was small After the vaccine of Biontech Pfizer the European medicament authority granted now also the vaccine of the US manufacturer Moderna a permission Topic picture, symbol picture Cologne, 06 01 2021 Foto:xC.xHardtx/xFuturexImage

05 January 2021, Brandenburg, Cottbus: In the vaccination centre Cottbus there is a small ampoule with a cannula for the vaccination against Covid-19 with the vaccine of Biontech/Pfizer. Photo: Patrick Pleul/dpa-Zentralbild/ZB

Winden Themenbild - Coronavirus, Coronapandemie, Impfen, Silhouette einer Impfspritze, Coronaspritze und einer Hand mit einem Gummihandschuh, Impfstoff, Impfdose, Themenbild - Coronavirus, Coronapandemie, Impfen, Silhouette einer Impfspritze, Coronaspritze und einer Hand mit einem Gummihandschuh, Impfstoff, Impfdose, Coronavirus, Coronapandemie, Impfspritze, Coronaspritze, Nadel als Silhouette, Scherenschnittbild zum verabreichen, spritzen des Impfstoffes. Im Hintergrund Bilder von AstraZeneca, Union Jack, Nationalflagge von Grossbritanien, EU Flagge, Europaische Flagge, Euroland, Nationalflagge von Amerika, Europakarte, Europaland, USA, Israel, Amerika Impfen, Impfbuch, Impfbescheinigung, Impfpass, Spritze, Coronaspritze, Nadel, Imp Copyright: xFleigx/xEibner-Pressefotox EP_dfg

Winden Themenbild - Coronavirus, Coronapandemie, Impfen, Silhouette einer Impfspritze, Coronaspritze und einer Hand mit einem Gummihandschuh, Impfstoff, Impfdose, Themenbild - Coronavirus, Coronapandemie, Impfen, Silhouette einer Impfspritze, Coronaspritze und einer Hand mit einem Gummihandschuh, Impfstoff, Impfdose, Coronavirus, Coronapandemie, Impfspritze, Coronaspritze, Nadel als Silhouette, Scherenschnittbild zum verabreichen, spritzen des Impfstoffes. Im Hintergrund Bilder von AstraZeneca, Union Jack, Nationalflagge von Grossbritanien, EU Flagge, Europaische Flagge, Euroland, Nationalflagge von Amerika, Europakarte, Europaland, USA, Israel, Amerika Impfen, Impfbuch, Impfbescheinigung, Impfpass, Spritze, Coronaspritze, Nadel, Imp Copyright: xFleigx/xEibner-Pressefotox EP_dfg

Winden Themenbild - Coronavirus, Coronapandemie, Impfen, Silhouette einer Impfspritze, Coronaspritze und einer Hand mit einem Gummihandschuh, Impfstoff, Impfdose, Themenbild - Coronavirus, Coronapandemie, Impfen, Silhouette einer Impfspritze, Coronaspritze und einer Hand mit einem Gummihandschuh, Impfstoff, Impfdose, Coronavirus, Coronapandemie, Impfspritze, Coronaspritze, Nadel als Silhouette, Scherenschnittbild zum verabreichen, spritzen des Impfstoffes. Im Hintergrund Bilder von AstraZeneca, Union Jack, Nationalflagge von Grossbritanien, EU Flagge, Europaische Flagge, Euroland, Nationalflagge von Amerika, Europakarte, Europaland, USA, Israel, Amerika Impfen, Impfbuch, Impfbescheinigung, Impfpass, Spritze, Coronaspritze, Nadel, Imp Copyright: xFleigx/xEibner-Pressefotox EP_dfg

Winden Themenbild - Coronavirus, Coronapandemie, Impfen, Silhouette einer Impfspritze, Coronaspritze und einer Hand mit einem Gummihandschuh, Impfstoff, Impfdose, Themenbild - Coronavirus, Coronapandemie, Impfen, Silhouette einer Impfspritze, Coronaspritze und einer Hand mit einem Gummihandschuh, Impfstoff, Impfdose, Coronavirus, Coronapandemie, Impfspritze, Coronaspritze, Nadel als Silhouette, Scherenschnittbild zum verabreichen, spritzen des Impfstoffes. Im Hintergrund Bilder von AstraZeneca, Union Jack, Nationalflagge von Grossbritanien, EU Flagge, Europaische Flagge, Euroland, Nationalflagge von Amerika, Europakarte, Europaland, USA, Israel, Amerika Impfen, Impfbuch, Impfbescheinigung, Impfpass, Spritze, Coronaspritze, Nadel, Imp Copyright: xFleigx/xEibner-Pressefotox EP_dfg

Vaccination of residents and nursing staff versus the COVID-19 virus with the vaccine from Biontech and Pfizer in the Dominus VI retirement home. Alcala de Henares, 04.01.2021 | usage worldwide

Vaccination of residents and nursing staff versus the COVID-19 virus with the vaccine from Biontech and Pfizer in the Dominus VI retirement home. Alcala de Henares, 04.01.2021 | usage worldwide

29 December 2020, Lower Saxony, Nordhorn: A syringe is drawn up with the Corona vaccine from Biontech/Pfizer. Photo: Sina Schuldt/dpa

29 December 2020, Lower Saxony, Nordhorn: A syringe is drawn up with the Corona vaccine from Biontech/Pfizer. Photo: Sina Schuldt/dpa

29 December 2020, Lower Saxony, Nordhorn: A bottle of Biontech/Pfizer's Corona vaccine sits on a table at a vaccination center. Photo: Sina Schuldt/dpa

Impfstart in Koeln erste Bewohner von Pflegeheimen werden geimpft Symbolbild, Symbolfoto Impfpass mit einer Ampulle von Biontech Pfizer Impfstoff und Spritze wahrend der ersten Impfung in Pflegeheimen Koeln Nordrhein-Westfalen Deutschland *** Vaccination start in Cologne first residents of nursing homes are vaccinated symbol picture, symbol photo vaccination passport with an ampoule of Biontech Pfizer vaccine and syringe during the first vaccination in nursing homes Cologne North Rhine Westphalia Germany

FOTOMONTAGE-Themenbild,Symbolfoto:Impfstoff von Biontech Pfizer vor Zulassung in Deutschland. Medizinisches Personal haelt eine Impfspritze und eine Impfdose mit Impfstoff gegen das Coronavirus. Impfung mit Einwegspritze und Impfstoff zur Injektion mit einer Kanuele. Haende in Schutzhandschuhen. *** FOTOMONTAGE Theme image,symbol photo Vaccine from Biontech Pfizer before approval in Germany Medical personnel holding a vaccine syringe and a vaccine canister with vaccine against the coronavirus Vaccination with disposable syringe and vaccine for injection with a canula Hands in protective gloves

FOTOMONTAGE-Themenbild,Symbolfoto:Impfstoff von Biontech Pfizer vor Zulassung in Deutschland. Medizinisches Personal haelt eine Impfspritze und eine Impfdose mit Impfstoff gegen das Coronavirus. Impfung mit Einwegspritze und Impfstoff zur Injektion mit einer Kanuele. Haende in Schutzhandschuhen. *** FOTOMONTAGE Theme image,symbol photo Vaccine from Biontech Pfizer before approval in Germany Medical personnel holding a vaccine syringe and a vaccine canister with vaccine against the coronavirus Vaccination with disposable syringe and vaccine for injection with a canula Hands in protective gloves

Impfstoff soll am 23.12.2020 zur Verfuegung stehen. Themenbild,Symbolfoto:Corona Impfstoff. Schon im Dezember sollen die Impfstoffe zur Verfuegung stehen und geimpft werden. Eine Einwegspritze und Impfdosen mit Impfstoff zur Injektion mit einer Kanuele. *** Vaccine to be available 23 12 2020 Topic Image,Symbol Photo Corona Vaccine Vaccines to be available and vaccinated as early as December A disposable syringe and doses of vaccine to be injected with a needle

Symbolbild Impfung durch AstraZeneca Impfstoff gegen Covid-19, Bescheinigung im Impfpass Symbolfoto, Impfung durch einen Covid-19 Impfstoff zur Bekaempfung der Corona Pandemie des Pharma und Impfstoffhersteller AstraZeneca aus Grossbritanien und Dokumentation im Impfpass. *** Symbol picture Vaccination by AstraZeneca vaccine against Covid 19, certificate in the vaccination passport Symbol photo, vaccination by a Covid 19 vaccine to fight the Corona Pandemic of the pharmaceutical and vaccine manufacturer AstraZeneca from Great Britain and documentation in the vaccination passport

Tuebingen 03.12.2020 Symbolbild: Der Corona Impfstoff des biopharmazeutisches Unternehmen BioNTech hat in Gro?britannien zugelassen bekommen. Bild nur zur redaktionelle Nutzung *** Tuebingen 03 12 2020 Symbol picture The corona vaccine of the biopharmaceutical company BioNTech has been approved in Great Britain Picture for editorial use only ULMER

Tuebingen 29.11.2020 Symbolbild: Das Tuebinger biopharmazeutisches Unternehmen CureVac forscht unter Hochdruck an einem Corona Impfstoff. Bild nur zur redaktionelle Nutzung *** Tuebingen 29 11 2020 Symbol picture The Tuebingen-based biopharmaceutical company CureVac is conducting high-pressure research on a corona vaccine Picture for editorial use only ULMER

Coronavirus Impfung: Moderna *** Corona virus vaccination: Moderna US-Pharmakonzern Moderna liefert vielversprechnde Daten fur ihren produzierten Corona-Impfstoff. Im Bild: Illustration mit dem Logo von moderna sowie einer Spritze mit Kanule. Wien, ?sterreich. 21.11.2020 *** Corona vaccine: US pharma corporation Moderna announces promising data for their Corona-Vaccine. Picture: Illustration including the emblem of moderna and a injection with a cannula. Vienna, Austria. 21. November 2020 Favoriten *** Favoriten PUBLICATIONxNOTxINxAUT

Kurz nach dem Mainzer Unternehmen Biontech und seinem Partner Pfizer verkundet auch US-Konkurrent Moderna einen Erfolg mit einem Corona-Impfstoff: Der Impfstoff mRNA-1273 soll eine 95-prozentige Wirksamkeit haben. Themenbild, Symbolbild 17.11.2020 *** Shortly after the Mainz-based company Biontech and its partner Pfizer, US competitor Moderna also announces a success with a corona vaccine The vaccine mRNA 1273 is said to have a 95 percent effectiveness Theme picture, symbol picture 17 11 2020 Foto:xC.xHardtx/xFuturexImage

Kurz nach dem Mainzer Unternehmen Biontech und seinem Partner Pfizer verkundet auch US-Konkurrent Moderna einen Erfolg mit einem Corona-Impfstoff: Der Impfstoff mRNA-1273 soll eine 95-prozentige Wirksamkeit haben. Themenbild, Symbolbild 17.11.2020 *** Shortly after the Mainz-based company Biontech and its partner Pfizer, US competitor Moderna also announces a success with a corona vaccine The vaccine mRNA 1273 is said to have a 95 percent effectiveness Theme picture, symbol picture 17 11 2020 Foto:xC.xHardtx/xFuturexImage

Kurz nach dem Mainzer Unternehmen Biontech und seinem Partner Pfizer verkundet auch US-Konkurrent Moderna einen Erfolg mit einem Corona-Impfstoff: Der Impfstoff mRNA-1273 soll eine 95-prozentige Wirksamkeit haben. Themenbild, Symbolbild 17.11.2020 *** Shortly after the Mainz-based company Biontech and its partner Pfizer, US competitor Moderna also announces a success with a corona vaccine The vaccine mRNA 1273 is said to have a 95 percent effectiveness Theme picture, symbol picture 17 11 2020 Foto:xC.xHardtx/xFuturexImage

Kurz nach dem Mainzer Unternehmen Biontech und seinem Partner Pfizer verkundet auch US-Konkurrent Moderna einen Erfolg mit einem Corona-Impfstoff: Der Impfstoff mRNA-1273 soll eine 95-prozentige Wirksamkeit haben. Themenbild, Symbolbild 17.11.2020 *** Shortly after the Mainz-based company Biontech and its partner Pfizer, US competitor Moderna also announces a success with a corona vaccine The vaccine mRNA 1273 is said to have a 95 percent effectiveness Theme picture, symbol picture 17 11 2020 Foto:xC.xHardtx/xFuturexImage

Symbolbild Corona-Impfstoff der Firma MODERNA, Hand mit Spritze, Corona-Krise, Baden-Wurttemberg, Deutschland Coronavirus Impfstoff *** Symbol picture Corona vaccine of the company MODERNA, hand with syringe, corona crisis, Baden Wurttemberg, Germany Coronavirus vaccine

Symbolbild Corona-Impfstoff der Firma MODERNA, Mann mit Spritze, Corona-Krise, Baden-Wurttemberg, Deutschland Coronavirus *** Symbol image Corona vaccine of the company MODERNA, man with syringe, corona crisis, Baden Wurttemberg, Germany Coronavirus

Symbolbild Corona-Impfstoff, Arztin mit Spritze, Corona-Krise, Baden-Wurttemberg, Deutschland Coronavirus *** Symbol image Corona vaccine, doctor with syringe, corona crisis, Baden Wurttemberg, Germany Coronavirus

10.09.2020, Pharmaindustrie : Moderna, Inc, ist ein in Cambridge, Massachusetts, ansassiges Biotechnologieunternehmen. 10.09.2020, Pharmaindustrie 10.09.2020, Pharmaindustrie *** 10 09 2020, pharmaceutical industry Moderna, Inc, is a Cambridge, Massachusetts-based biotechnology company 10 09 2020, pharmaceutical industry 10 09 2020, pharmaceutical industry

10.09.2020, Pharmaindustrie : Curevac N.V. ist ein biopharmazeutisches Unternehmen mit Sitz in den Niederlanden und Zentrale in Tubingen Deutschland. 10.09.2020, Pharmaindustrie 10.09.2020, Pharmaindustrie *** 10 09 2020, pharmaceutical industry Curevac N V is a biopharmaceutical company based in the Netherlands with headquarters in Tubingen Germany 10 09 2020, pharmaceutical industry 10 09 2020, pharmaceutical industry

10.09.2020, Pharmaindustrie : Curevac N.V. ist ein biopharmazeutisches Unternehmen mit Sitz in den Niederlanden und Zentrale in Tubingen Deutschland. 10.09.2020, Pharmaindustrie 10.09.2020, Pharmaindustrie *** 10 09 2020, pharmaceutical industry Curevac N V is a biopharmaceutical company based in the Netherlands with headquarters in Tubingen Germany 10 09 2020, pharmaceutical industry 10 09 2020, pharmaceutical industry

25.08.2020, Impfstoff 25.08.2020, Impfstoff 25.08.2020, Impfstoff *** 25 08 2020, vaccine 25 08 2020, vaccine 25 08 2020, vaccine

Themenbild,Symbolfoto:Corona Impfstoff. Eine Hand in Gummihandschuhe gehuellt haelt eine Einwegspritze mit Impfstoff zur Injektion mit einer Kanuele. BIONTECH Biotechnologie Unternehmen. *** Theme picture,symbol photo Corona vaccine A hand wrapped in rubber gloves holds a disposable syringe with vaccine for injection with a cannula BIONTECH Biotechnology Company

Tuebingen Themenfoto Corona Impfstoff, Bund investiert in Curevac, Impfstoffentwickler Curevac, 15.06.20 Uebersichtsbild, Firmenzentrale, Luftaufnahme, Themenfoto Corona Impfstoff, Bund investiert in Curevac, Impfstoffentwickler Curevac, 15.06.20, *** Tuebingen theme photo Corona vaccine, German government invests in Curevac, vaccine developer Curevac, 15 06 20 overview photo, company headquarters, aerial view, theme photo Corona vaccine, German government invests in Curevac, vaccine developer Curevac, 15 06 20, Copyright: xEibner-Pressefotox EP_swa

Tuebingen Themenfoto Corona Impfstoff, Bund investiert in Curevac, Impfstoffentwickler Curevac, 15.06.20 Firmenschild CureVac, Tuebingen, Themenfoto Corona Impfstoff, Bund investiert in Curevac, Impfstoffentwickler Curevac, 15.06.20, *** Tuebingen Topic photo Corona vaccine, German government invests in Curevac, vaccine developer Curevac, 15 06 20 Company sign CureVac, Tuebingen, Topic photo Corona vaccine, German government invests in Curevac, vaccine developer Curevac, 15 06 20, Copyright: xEibner-Pressefotox EP_swa

Eine Virologin posiert mit einer Spritze zur Impfung gegen das Corona-Virus. Symbolfoto mit Model Nurnberg, 23.04.2020 *** A virologist poses with a syringe for vaccination against the corona virus Symbol photo with model Nuremberg, 23 04 2020 Foto:xC.xHardtx/xFuturexImage